Cargando…
Influencing factors on serum 25-hydroxyvitamin D(3) levels in Japanese chronic hepatitis C patients
BACKGROUND: Serum 25-hydroxyvitamin D(3) levels are generally lower in chronic hepatitis C patients than in healthy individuals. The purpose of this study is to clarify the factors which affect serum 25-hydroxyvitamin D(3) levels using data obtained from Japanese chronic hepatitis C patients. METHOD...
Autores principales: | Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Yoshizawa, Kai, Abe, Hiroshi, Asano, Toru, Ohkubo, Yusuke, Araki, Masahiro, Ikegami, Tadashi, Kondo, Chisa, Itokawa, Norio, Nakagawa, Ai, Arai, Taeang, Matsushita, Yoko, Nakatsuka, Katsuhisa, Furihata, Tomomi, Chuganji, Yoshimichi, Matsuzaki, Yasushi, Aizawa, Yoshio, Iwakiri, Katsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543479/ https://www.ncbi.nlm.nih.gov/pubmed/26286329 http://dx.doi.org/10.1186/s12879-015-1020-y |
Ejemplares similares
-
Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study
por: Atsukawa, Masanori, et al.
Publicado: (2013) -
Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial
por: Okubo, Tomomi, et al.
Publicado: (2021) -
Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B
por: Itokawa, Norio, et al.
Publicado: (2021) -
Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study
por: Arai, Taeang, et al.
Publicado: (2022) -
How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis
por: Atsukawa, Masanori, et al.
Publicado: (2023)